Patient clearance time (tp) with different vascular access types

The International Journal of Artificial Organs
Evangelia C DounousiKonstantinos P Katopodis

Abstract

The dialysis delivered dose is limited by the rate at which urea can be transferred from the different body compartments. The time needed to clear the peripheral compartments of the body has been called the patient clearance time (tp). The aim of the study was to compare delivered dialysis dose using the tp index between patients dialyzed through a permanent central venous catheter (CVC) and patients with an arteriovenous fistula (AVF). The study included 48 stable hemodialyzed patients. Patients were classified into two groups according to their vascular access type. The first group included 24 patients dialyzed through a permanent CVC and the second group consisted of 24 patients with a mature AVF. The following parameters were calculated twice for each patient: tp, Kt/V adjusted for the tp. tp was lower in the AVF dialysis modality than in CVC (26 ± 7 vs. 42 ± 14 min, p<0.001) while the (eqKt/V)tp was higher in AVF than in CVC dialysis (1.36 ± 0.11 vs. 1.19 ± 0.13, p<0.001). The patient clearance time is lower in AVF than in CVC dialysis, and this is accompanied by a higher delivered dialysis dose.

References

Dec 1, 1992·Kidney International·D SchneditzJ T Daugirdas
Feb 1, 1992·Clinical Physics and Physiological Measurement : an Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Für Medizinische Physik and the European Federation of Organisations for Medical Physics·S W SmyeJ T Brocklebank
Sep 1, 1991·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·T Reynolds, C P Appleton
Dec 1, 1988·Kidney International·L A PedriniS Rasmy
Sep 1, 1985·Kidney International·F A Gotch, J A Sargent
Sep 1, 1995·Kidney International·M M BankheadR A Star
May 1, 1994·Kidney International·T A Depner
Oct 1, 1993·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R A Sherman
Nov 1, 1993·Journal of the American Society of Nephrology : JASN·J T Daugirdas
Jan 1, 1993·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J E TattersallR N Greenwood
Jul 1, 1994·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·D Schneditz, J T Daugirdas
Jul 1, 1995·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·J T Daugirdas, D Schneditz
Nov 1, 1995·Journal of the American Society of Nephrology : JASN·D SchneditzN W Levin
Feb 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M LeblancC Déziel
Mar 1, 1996·Journal of the American Society of Nephrology : JASN·T A DepnerK Pu
Jan 1, 1996·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J E TattersallR N Greenwood
Dec 1, 1996·Kidney International·J E TattersallK Farrington
Feb 1, 1997·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A Besarab, R Sherman
Mar 7, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Dec 25, 2003·Journal of the American Society of Nephrology : JASN·John T DaugirdasUNKNOWN Hemodialysis Study Group

❮ Previous
Next ❯

Software Mentioned

SPSS®

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Haimanot WasseWilliam M McClellan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Steven M ShechterNadia Zalunardo
© 2021 Meta ULC. All rights reserved